glutathione for als in the Nervous System as a Potential Therapeutic Target to Control the Development and Progression of Amyotrophic Lateral Sclerosis Health Benefits of Glutathione
Description
10.1016/j.autrev.2020.102647 Autoimmun
Main methods (1) All rats intraperitoneally received thiopental (20, 30, 40, and 50 mg/kg) while medication BPC 157 (10 g/kg, 10 ng/kg, and 10 pg/kg) was given intraperitoneally at 5 min before thiopental

injections of 200 nmol kg 1 MK-801 (n = 8 mice and n = 4 cages), 600 nmol kg 1 MK-801 (n = 7 mice and n = 4 cages) or vehicle (isotonic saline, n = 7 mice and n = 4 cages) for 7 days

However, because anecdotal reports of increases in serum creatinine level exist, we recommend close monitoring of renal function according to the stage of CKD, for example, monitoring in 3-month intervals in patients with CKD stage 34
